Bulk Silica Powder: Packaging Options, MOQ and Bulk Pricing Guide

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Grace Syloid: Silica Product Range for Coatings, Pharma and Food
  • Keywords: silica for paint
  • Published: 2026-11-20 01:46:48
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Quartz Sand Price: 2026 Price Ranges by Purity and Mesh Size

Silica Stocks: Publicly Listed Silica and Quartz Companies to Know
Silica Aerogel Powder: Properties, Applications and How It Compares to Other Insulators
Ultra Pure Silica: What Purity Level You Need and Which Industries Use It
Physical and polymorphic stability also depend on the way of loading. Prednisolone underwent a polymorphic transformation from form I to form II within pores when it was loaded into MSNs with the solvent-evaporation approach, whereas melt-loading retained the original polymorph. This means that contacts between the solvent, API, and silica, and the presence of residual solvent can template some polymorphic structures. Furthermore, confinement within thin channels stabilizes metastable polymorphs that would otherwise really swiftly convert into the thermodynamically stable polymorph in the bulk. This offers an opportunity to selectively stabilize desired polymorphs by pore size [ 48 ]. Dwyer et al. showed that confinement in nanopores is capable of stabilizing metastable polymorphs or even forming new polymorphs not accessible in the bulk. For instance, fenofibrate crystallized in favored metastable states during confinement in mesoporous matrices, while other APIs formed nanoscale crystals of different thermodynamic properties. The above findings show that MSNs are not only stabilizers but also nanocrystallization chambers that can govern polymorphic selection and routes [ 49 ].
Admatechs Silica: Submicron Spherical Silica Products and Applications

Silica vs Silicone: Key Differences in Structure, Properties and Uses

What is silica (SiO₂)?

silica OEM Magnetic particles were synthesized with an iron-containing coating. The model drugs were safranin O and hydrocortisone. The particles were functionalized with a bulky azo derivative to act as a gatekeeper and stop early leakage of the drug. In vitro release models have demonstrated that most of the drug is released only in the colon, as desired. This is owing to the reductive environment in the colon (the presence of the azoreductase enzyme), where the enzymatic degradation of the azo bond resulted in controlled release. In addition, in vivo pharmacokinetic studies were conducted in a rat model of induced colitis to test the effect of the magnetic field during therapy. The findings boosted when the rats wore a magnetic belt, which extended the retention time of the particles in the desired areas [ 75 ]. Zhang et al. presented a study in which magnetic silica nanoparticles (filled with sulforaphane) were developed for the treatment of myocardial infarction [ 38 ]. In mouse models, effective accumulation was observed in the infarcted zone after the application of an external magnetic field [ 33, 75 ]. These results show the potential of using magnetic particles with magnetic field guidance [ 33 ]. Radhakrishnan et al. developed a drug delivery system (DDS) loaded with carboplatin for targeted lung cancer therapy [ 63 ]. The DDS was core-shell mesoporous silica functionalized with folic acid. Initially, the drug loading capability of the functionalized carrier was more than twice as high per surface unit compared to the non-functionalized carrier due to the anchored -NH 2 groups. The drug release was sustained but limited (up to 36%) in the case of the functionalized particle, similarly to previous cases. This is most likely owing to the stronger interactions between the amine groups and the carboplatin. The amino-functionalized particles were further functionalized with folic acid to increase cellular uptake of the particles, demonstrating the potential of folic acid-targeted therapy [ 63, 65, 76 ]. Cancer cells typically overexpress folate receptors, resulting in folate-mediated internalization that preferentially targets these cells [ 63, 76 ]. This was demonstrated in a drug-mediated cytotoxicity analysis where amino- and folate-functionalized particles were evaluated and compared. Much greater cytotoxicity was observed in cells overexpressing folate receptors [ 63 ]. Similar research was carried out by Shirani et al., where folic acid functionalized MSNs were loaded with gemcitabine as a model drug, to investigate its potential in cancer treatment, while actively targeting cancer cells [ 70 ]. Outcomes have shown that higher cellular uptake (HeLa and K562 cells) was observed in the case of the functionalized particles, compared with the non-functionalized carriers [ 70 ]. Jafarpour et al. demonstrated the importance of functionalizing the carriers to accomplish targeted therapy utilizing methotrexate as a model drug [ 76 ]. The particles were grafted with a copolymer to act as a pH-responsive gatekeeper and folic acid to actively target cancer cells [ 76 ]. Ortiz et al. similarly designed a pH-responsive DDS, loaded with the anticancer drug doxorubicin [ 11 ]. The particles were functionalized with transferrin through a pH-sensitive linker as a gatekeeper, controlling the release kinetics and preventing early leakage of the drug [ 11 ]. An interesting breast cancer therapy was published by Mal et al. using doxorubicin as API and mesoporous silica as a carrier [ 65 ]. The amine-functionalized MSNs were PEGylated and then conjugated with folic acid or hyaluronic acid. It was also published that coating the nanoparticles with polydopamine (PDA) and polyethylene glycol (PEG) brings about prolonged doxorubicin release from MSNs [ 77 ]. These conjugates enabled ligand-mediated targeted drug delivery [ 65 ]. Researchers have developed a successful DDS that targets cancer cells, thus staying away from the side effects associated with doxorubicin in conventional cancer therapy. This is important because in vitro cytotoxicity studies have shown that the free drug has higher cytotoxicity than the nanocarriers [ 65 ]. Shahbaz et al. developed a redox-responsive silica nanocarrier loaded with paclitaxel to target breast cancer cells [ 67 ]. The amine-functionalized silica core was coated with disulfide-functionalized non-porous silica shell. Then the core-shell carriers were further coated with polyethylene glycol via disulfide linkages. In vitro drug release assay verified the correlation between the redox potential of the environment and the release kinetics. This is an important finding, as it has been revealed that cancer cells possess a higher redox ability than healthy cells. This provides controlled paclitaxel release for targeted therapy. According to cell uptake and cell viability assays, this DDS is noticeably more effective than free paclitaxel, making this nanocarrier an exciting prospect [ 67 ]. These illustrations highlight the importance of surface functionalization and employing stimuli-responsive gatekeepers to attain productive targeted therapy.

What is the difference between fumed silica and precipitated silica?

wollastonite

What drives silica raw material prices?

silica melting point

Cite this article: Silica Raw Materials News. "Silica as a Clarifying Agent: Uses in Beer, Wine and Beverages ." Published 2026-11-20 01:46:48. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.